Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose Supplementation in Premature Infants
NCT00616876Phase 2Completed
- Sponsor
- Bnai Zion Medical Center
- Start
- Feb 2005
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lactulose in necrotizing enterocolitis (NEC), late-onset neonatal sepsis (LONS), sponsored by Bnai Zion Medical Center. Started Feb 2005; status: completed.
02
Drugs
lactulose
03
Conditions
necrotizing enterocolitis (NEC)late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NCT00616876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616876.